This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version    RSS    Subscribe    Unsubscribe   Archive    Media Kit Nov. 13, 2013

Home   About ITNS   Members Only   Membership   Education   Store   Careers   Research   Support   Contact Us  



Prevent Hazardous Drug Exposure

PhaSeal has been the only clinically proven closed-system drug transfer device for the safe handling of hazardous drugs.

 



2013 ITNS Research Grant award winner
Submitted by ITNS Research Director Sandy Cupples, PhD RN
Through its Research Grant Program, ITNS is able to foster nursing scholarship and advance transplant nursing practice. ITNS is pleased to announce that a $2,500 research grant was awarded to Mark Lockwood, MSN, RN, CCRC. Mark is the Clinical Research Nurse at the Solid Organ Transplant/Islet Cell Transplant Program — University of Chicago Hospitals Transplant Center. He is currently a doctoral student at the Oregon Health and Science University. The title of Mark's study is: "A Prospective Cohort Study to Assess Psychosocial Factors that Influence Completion of the Pre-Renal Transplant Evaluation at an Urban Transplant Center." Mark will present his findings at the 23rd Annual ITNS Symposium to be held 27-29 September 2014 in Houston, Texas. Congratulations, Mark!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




ASSOCIATION NEWS


ITNS Congratulates Hanna Burkhalter
Hanna Burkhalter completed her PhD in Nursing Science (supervised by Professor Sabina De Geest), Institute of Nursing Science, Faculty of Medicine, University of Basel, Nov. 6, 2013 with defense of the dissertation entitled: "Bright Light Therapy in Renal Transplant Recipients with Sleep-Wake Disturbance." Congratulations Dr. Burkhalter!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


ITNS Congratulates Coby Annema on her recent publication
Annema C., Roodbol P.F., Stewart R.E. & Ranchor A.V. Validation of the Dutch version of the Transplant Effects Questionnaire in liver transplant recipients. Research in Nursing & Health, 2013, 36, 203-215.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


The call for abstracts for the 23rd Annual ITNS Symposium is now open!
Submit your abstract before the 15 January 2014 deadline.


INDUSTRY NEWS


U.S. Congress votes to end the ban on HIV organ transplants and research
Think Progress
The U.S. House of Representatives recently gave final approval to the HIV Organ Policy Equity Act, a bill that will end a 25-year ban on using HIV-positive donors' organs for any purpose, including medical research. If the Department of Health and Human Services concludes that transplanting organs between HIV-positive Americans is safe and effective under scientific guidelines set by the law, such transplants will then become legal and it will no longer be a crime for HIV-positive Americans to donate their organs. President Barack Obama is expected to sign the legislation into law.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Like ITNS on Facebook! Visit the ITNS Facebook page for the latest ITNS and transplant news.


Australia ranks 21st for organ donation
Ninemsn
Organ donation in Australia is way behind the world leaders, according to international rankings that place the country at 21st. Spain is the world leader, and France, the U.S., U.K., Belgium and Norway are among the countries with higher proportions of donors than Australia. The figures compiled by Sharelife Australia draw on international donor data published by the Council of Europe.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


First study of its kind shows that all-oral treatment regimen prevents hepatitis C recurrence in liver transplant recipients who received allografts
Newswire via Reuters
For the first time, researchers have been able to prevent the recurrence of hepatitis C virus infection in a large proportion of patients (64 percent, n=25/39) who undergo liver transplantation for cirrhosis complicated by hepatocellular carcinoma. This success was achieved with an interferon-free treatment regimen containing the oral antivirals sofosbuvir, an investigational agent and ribavirin.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Birmingham research tackles liver transplant failure
Health Canal
The re-infection of transplanted livers with hepatitis C virus — which can irreparably damage the new organ — could be halted by administering a drug which blocks the virus entering the liver, research from the University of Birmingham being presented at the Liver Meeting demonstrates.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Crossing state lines for an organ transplant (ABC News)
The importance of social support in organ transplantation outcomes (By Maria Frisch)
New method may improve face transplant matches (Newsday)
5-week-old baby's kidneys successfully used in organ transplant (The Daily Mirror)
Widely prescribed statin could help organ-transplant patients (Scientific American)

Don't be left behind. Click here to see what else you missed.


New HCV drugs offer hope after transplant
MedPage Today
The advent of new all-oral regimens for hepatitis C offers hope to patients who have undergone liver transplant and had the disease recur, a researcher said here. Patients with hepatitis C who get a new liver universally have a recurrence of the disease in the new organ, according to Dr. Michael Charlton of the Mayo Clinic in Rochester.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Pfizer says organ transplant drug fails in study
The Associated Press via Bloomberg Businessweek
Pfizer recently said its organ transplant drug Rapamune failed in a clinical trial. Rapamune as an immunosuppressant drug approved to prevent organ rejection in patients who have received a kidney transplant, and it is recommended for use in patients who have just had a transplant. The latest trial compared patients who were treated with an older drug, tacrolimus, to patients who started on tacrolimus and transitioned to treatment with Rapamune 3 to 5months after their transplant procedure.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Healthy brains impacting organ donation — but why?
By Denise A. Valenti
Brain death occurs when there is a total and irreversible loss of all the brain's functions. Organ donation most commonly occurs when there is a brain death. Dr. Andreas Kramer and colleagues at the University of Calgary, Alberta, recently published a study investigating changes in the availability of donated organ tissue over the last decade. The rate of organ donation is in decline as the rate of neurologic death in brain trauma has dramatically reduced. But to what can we attribute the improved outcomes in these brain trauma cases?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Lung transplant 'patient 45' remembered 30 years on
CBC News
Lung transplant recipients, doctors and nurses are celebrating the 30th anniversary of the world's first successful lung transplant in Toronto. In 1983, Tom Hall was the 45th patient in the world to receive a single lung at what was then Toronto General Hospital. Tom Hall visits Paris, five years after his lung transplant. Before his successful operation, transplant recipients had not lived beyond a few days or weeks. (Courtesy University Health Network) Hall lived more than six years — the first to survive for more than days or weeks after receiving the organ.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ITNS Insider

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Brie Ragland, Content Editor, 469.420.2639  
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the ITNS Insider was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Nov. 14, 2013
Nov. 7, 2013
Oct. 31, 2013
Oct. 24, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063